Publication details

Fluorodeoxyglucose positron emission tomography in multiple myeloma, solitary plasmocytoma and monoclonal gammapathy of unknown significance

Authors

ADAM Zdeněk BOLČÁK Karol STANÍČEK J. BÜCHLER Tomáš POUR Luděk KREJČÍ Marta PRÁŠEK J. NEUBAUER J. VORLÍČEK Jiří HÁJEK Roman

Year of publication 2007
Type Article in Periodical
Magazine / Source Neoplasma
MU Faculty or unit

Faculty of Medicine

Citation
Field Oncology and hematology
Keywords multiple myeloma; monoclonal gammapathy of unknown significance; plasmocytoma; PDG-PET
Description The aim of our study was to evaluate the role of fluorine-18 fluorodeoxyglucose positron emission tomography (FDGPET) in 49 patients with plasma cell malignancies. FDG-PET results were verified by conventional imaging methods, including plain radiographs, magnetic resonance imaging (MRI) and computer tomography (CT). We conclude that FDG PET might contribute to initial staging of MM patients with negative bone radiographs and is useful for the follow-up of patients in remission especially in non-secretory MM and in patients with large plasmocytoma (>5 cm) after radiochemotherapy.

You are running an old browser version. We recommend updating your browser to its latest version.

More info